PLx Pharma Valuation
Based on Macroaxis valuation methodology, the company cannot be evaluated at this time. PLx Pharma recent Real Value cannot be determined due to lack of data. The prevailing price of PLx Pharma is $0.0. Our model determines the value of PLx Pharma from analyzing the company fundamentals such as Shares Owned By Insiders of 15.39 %, current valuation of 5.49 M, and Return On Equity of -0.75 as well as examining its technical indicators and probability of bankruptcy.
PLx Pharma Total Value Analysis
PLx Pharma is at this time anticipated to have valuation of 5.49 M with market capitalization of 2.53 M, debt of 202 K, and cash on hands of 35.73 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the PLx Pharma fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
5.49 M | 2.53 M | 202 K | 35.73 M |
PLx Pharma Investor Information
About 15.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.58. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. PLx Pharma recorded a loss per share of 0.39. The entity last dividend was issued on the 20th of April 2017. The firm had 1:8 split on the 20th of April 2017. Based on the key measurements obtained from PLx Pharma's financial statements, PLx Pharma is not in a good financial situation at the moment. It has a very high risk of going through financial straits in February.PLx Pharma Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. PLx Pharma has an asset utilization ratio of 10.71 percent. This connotes that the Company is making $0.11 for each dollar of assets. An increasing asset utilization means that PLx Pharma is more efficient with each dollar of assets it utilizes for everyday operations.PLx Pharma Ownership Allocation
PLx Pharma owns a total of 29.14 Million outstanding shares. PLx Pharma holds 15.39 pct. of its outstanding shares held by insiders and 23.25 pct. owned by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.PLx Pharma Profitability Analysis
The company reported the previous year's revenue of 8.21 M. Net Loss for the year was (46.12 M) with profit before overhead, payroll, taxes, and interest of 3.4 M.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in median. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in PLx Stock
If you are still planning to invest in PLx Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PLx Pharma's history and understand the potential risks before investing.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |